Quest Diagnostics
DGX
#842
Rank
โ‚น2.660 T
Marketcap
โ‚น24,180
Share price
-0.18%
Change (1 day)
47.34%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น954.48

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น949.59. In 2025 the company made an earnings per share (EPS) of โ‚น827.39 an increase over its 2024 EPS that were of โ‚น725.72.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น954.4815.36%
2025โ‚น827.3914.01%
2024โ‚น725.722.5%
2023โ‚น708.00-5.83%
2022โ‚น751.84-49.21%
2021โ‚น1,48049.72%
2020โ‚น988.7766.67%
2019โ‚น593.2618%
2018โ‚น502.78-4.26%
2017โ‚น525.1723.19%
2016โ‚น426.29-7.11%
2015โ‚น458.9428.46%
2014โ‚น357.26-31.61%
2013โ‚น522.3760.46%
2012โ‚น325.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,145 20.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น66.39-106.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น23.32-102.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น185.14-80.50%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.59-102.06%๐Ÿ‡บ๐Ÿ‡ธ USA